244 related articles for article (PubMed ID: 36763506)
1. Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype.
Li Y; Kubo H; Yu D; Yang Y; Johnson JP; Eaton DM; Berretta RM; Foster M; McKinsey TA; Yu J; Elrod JW; Chen X; Houser SR
Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H443-H460. PubMed ID: 36763506
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction.
Kanashiro-Takeuchi RM; Takeuchi LM; Dulce RA; Kazmierczak K; Balkan W; Cai R; Sha W; Schally AV; Hare JM
Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H739-H750. PubMed ID: 36897749
[TBL] [Abstract][Full Text] [Related]
3. Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a "2-Hit" Murine Model.
LaPenna KB; Li Z; Doiron JE; Sharp TE; Xia H; Moles K; Koul K; Wang JS; Polhemus DJ; Goodchild TT; Patel RB; Shah SJ; Lefer DJ
J Am Heart Assoc; 2023 Feb; 12(4):e028480. PubMed ID: 36752224
[TBL] [Abstract][Full Text] [Related]
4. The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.
Withaar C; Meems LMG; Markousis-Mavrogenis G; Boogerd CJ; Silljé HHW; Schouten EM; Dokter MM; Voors AA; Westenbrink BD; Lam CSP; de Boer RA
Cardiovasc Res; 2021 Jul; 117(9):2108-2124. PubMed ID: 32871009
[TBL] [Abstract][Full Text] [Related]
5. Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Wu H; Tang LX; Wang XM; Li LP; Chen XK; He YJ; Yang DZ; Shi Y; Shou JL; Zhang ZS; Wang L; Lu BJ; An SM; Zeng CY; Wang WE
Acta Pharmacol Sin; 2023 Jun; 44(6):1149-1160. PubMed ID: 36473990
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
[TBL] [Abstract][Full Text] [Related]
7. Impact of ovary-intact menopause in a mouse model of heart failure with preserved ejection fraction.
Troy AM; Normukhamedova D; Grothe D; Momen A; Zhou YQ; McFadden M; Hussain M; Billia F; Cheng HM
Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H522-H537. PubMed ID: 38180450
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
9. Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension.
Berger JH; Shi Y; Matsuura TR; Batmanov K; Chen X; Tam K; Marshall M; Kue R; Patel J; Taing R; Callaway R; Griffin J; Kovacs A; Shanthappa DH; Miller R; Zhang BB; Roth Flach RJ; Kelly DP
bioRxiv; 2024 Jun; ():. PubMed ID: 38895483
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of Jiming Powder in ameliorating heart failure with preserved ejection fraction based on metabolomics].
Wei XQ; Fan XY; Pu HY; Li S; Tang JY; Gao K; Li FH; Yu X; Guo SZ
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(17):4747-4760. PubMed ID: 37802814
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR/Myd88/TRAF/NF-κB and p38MAPK/CREB signaling pathways.
Dawuti A; Sun S; Wang R; Gong D; Liu R; Kong D; Yuan T; Zhou J; Lu Y; Wang S; Du G; Fang L
Biomed Pharmacother; 2023 Dec; 168():115837. PubMed ID: 37931518
[TBL] [Abstract][Full Text] [Related]
12. Cardiac reverse remodeling in a mouse model with many phenotypical features of heart failure with preserved ejection fraction: effects of modifying lifestyle.
Aidara ML; Walsh-Wilkinson É; Thibodeau SÈ; Labbé EA; Morin-Grandmont A; Gagnon G; Boudreau DK; Arsenault M; Bossé Y; Couët J
Am J Physiol Heart Circ Physiol; 2024 Apr; 326(4):H1017-H1036. PubMed ID: 38363584
[TBL] [Abstract][Full Text] [Related]
13. Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction.
Cochran JD; Yura Y; Thel MC; Doviak H; Polizio AH; Arai Y; Arai Y; Horitani K; Park E; Chavkin NW; Kour A; Sano S; Mahajan N; Evans M; Huba M; Naya NM; Sun H; Ban YH; Hirschi KK; Toldo S; Abbate A; Druley TE; Ruberg FL; Maurer MS; Ezekowitz JA; Dyck JRB; Walsh K
Circulation; 2023 Oct; 148(15):1165-1178. PubMed ID: 37681311
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide alleviates heart failure with preserved ejection fraction in mice by targeting mitochondrial abnormalities via PGC-1α.
Huang S; Chen X; Pan J; Zhang H; Ke J; Gao L; Yu Chang AC; Zhang J; Zhang H
Nitric Oxide; 2023 Jul; 136-137():12-23. PubMed ID: 37182786
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling.
Marunouchi T; Matsumura K; Fuji E; Iwamoto A; Tanonaka K
Pharmacology; 2024; 109(1):43-51. PubMed ID: 38016432
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
[TBL] [Abstract][Full Text] [Related]
17. Dapagliflozin Attenuates Heart Failure With Preserved Ejection Fraction Remodeling and Dysfunction by Elevating β-Hydroxybutyrate-activated Citrate Synthase.
Zhang X; Wang N; Fu P; An Y; Sun F; Wang C; Han X; Zhang Y; Yu X; Liu Y
J Cardiovasc Pharmacol; 2023 Nov; 82(5):375-388. PubMed ID: 37643027
[TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF.
Hohendanner F; Bode D; Primessnig U; Guthof T; Doerr R; Jeuthe S; Reimers S; Zhang K; Bach D; Wakula P; Pieske BM; Heinzel FR
J Mol Cell Cardiol; 2018 Feb; 115():10-19. PubMed ID: 29289652
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
[TBL] [Abstract][Full Text] [Related]
20. CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction.
Zhang N; Ma Q; You Y; Xia X; Xie C; Huang Y; Wang Z; Ye F; Yu Z; Xie X
Int J Biol Sci; 2022; 18(3):1271-1287. PubMed ID: 35173552
[No Abstract] [Full Text] [Related]
[Next] [New Search]